《Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospitalbased Study》.pdfVIP

80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* 1 1 1 1 YANG Yi , LANG Jing He , WANG You Fang , CHENG Xue Mei , 2 2 2 2,# CAI Yu Pin , LI Hui , ZHU Bao Li , and ZHANG Rui Fen This study compared HPV testing and combination-test strategies for the identification of liquid-based cytology (LCT) as performance women with positive screening results who require indicators for cervical cancer screening in a follow-up procedures. Single-test strategies include hospital-based study. A total of 61,193 outpatients cytology or HR-HPV DNA testing. Combination-test were screened initially by LCT. Samples with strategies include HR-HPV DNA testing as an adjunct screening results showing atypical squamous cells to cytology, or co-testing with both cytology and of undetermined significance (ASC-US) or worse HR-HPV DNA test[2]. HPV testing as an adjunct to were referred for colposcopy, and some samples cytology could resolve the ambiguous cytology were tested for high-risk HPV types with the Hybrid category of atypical squamous cells of undetermined Capture II system (HC II). Data on LCT (n=61,193)